Andrea Newkirk

Stock Analyst at Goldman Sachs

(2.81)
# 1,930
Out of 5,041 analysts
5
Total ratings
100%
Success rate
20.75%
Average return

Stocks Rated by Andrea Newkirk

Schrödinger
Sep 30, 2025
Initiates: Neutral
Price Target: $19
Current: $22.52
Upside: -15.63%
Revolution Medicines
Sep 12, 2025
Maintains: Buy
Price Target: $65$73
Current: $54.48
Upside: +33.99%
Alkermes
Jul 15, 2025
Initiates: Buy
Price Target: $43
Current: $29.80
Upside: +44.30%
89bio
Mar 14, 2025
Initiates: Neutral
Price Target: $11
Current: $14.79
Upside: -25.63%